Hutchmed
Clinical trials sponsored by Hutchmed, explained in plain language.
-
New hope for rare tumors: drug shows promise in japanese trial
Disease control CompletedThis study tested the drug surufatinib in 36 Japanese patients with neuroendocrine tumors that had stopped responding to standard treatments. The goal was to check safety and see if tumors shrank. Patients took the drug by mouth, and doctors monitored side effects and tumor chang…
Phase: PHASE1, PHASE2 • Sponsor: Hutchmed • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Breakfast matters: study tests drug with fatty meals
Knowledge-focused CompletedThis study looked at how eating a high-fat or low-fat meal changes the way the body absorbs an experimental drug called HMPL-523. Eighteen healthy adults took the drug under different meal conditions to measure drug levels and safety. The goal was to understand food effects, not …
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Knowledge-focused
Last updated May 01, 2026 20:57 UTC